K H Cowan - Concepedia

Concepedia

Author

K H Cowan

National Institutes of Health

Also Known As

K Cowan, K H Cowan, K. Cowan, K. H. Cowan, K.H. Cowan, KC Cowan, Kenneth H. Cowan, T Challenger

24

Publications

1.1K

Citations

12

H-Index

30

Concepts

All Affiliations

National Institutes of Health National Cancer Institute

KH

About

K H Cowan is an author at National Institutes of Health specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	604
2	Biochemistry	3	3	428
3	Cell Biology	2	2	148
4	Cellular Therapies	1	1	125
5	Immunology	1	1	125

K H Cowan

×

14

Publications

1.1K

Citations

12

H-Index

	Year	Citations
Glutathione S-transferases and drug resistance Charles S. Morrow, K H Cowan International Journal of Biochemistry BiochemistryMedicineMechanism Of ActionPharmacologyInhibitory Activity	1991	305
Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins. Jeffrey A. Moscow, Alan J. Townsend, K H Cowan Molecular Pharmacology	1989	172
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. K H Cowan, Jeffrey A. Moscow, Hui Huang, PubMed Cell TherapyBreast OncologyImmunologyTumor BiologyPaclitaxel Chemotherapy	1999	125
Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Christopher C. Benz, Max A. Keniry, James M. Ford, Molecular Pharmacology	1990	112
Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. Jack S. Cohen, Robbe C. Lyon, C. Chen, PubMed Breast OncologyChemoprevention StrategyMetabolomic ProfilingTumor BiologyMagnetic Resonance Spectra	1986	100
Phase I/II study of 72-hour infusional paclitaxel and doxorubicin with granulocyte colony-stimulating factor in patients with metastatic breast cancer. Jason S. Fisherman, K H Cowan, Marianne Noone, Journal of Clinical Oncology	1996	68
Breast cancer in young women: clinicopathologic correlation. P Bertheau, Steinberg Sm, K H Cowan, PubMed	1999	47
Combination paclitaxel (Taxol) and doxorubicin therapy for metastatic breast cancer. Joyce O’Shaughnessy, Jason S. Fisherman, K H Cowan PubMed	1994	30
A phase I study of topotecan followed sequentially by doxorubicin in patients with advanced malignancies. Anthony W. Tolcher, Joyce O’Shaughnessy, R B Weiss, PubMed Doxorubicin AdministrationsTumor BiologyDoxorubicin 45Malignant DiseaseMedicine	1997	27
Folate Transport and the Modulation of Antifolate Sensitivity in a Methotrexate-Resistant Human Breast Cancer Cell Line Katharine H. Dixon, J. B. Trepel, Simona Eng, Cancer Communications Transport KineticsTumor BiologyBreast OncologyOncologyAntifolate Sensitivity	1991	23

Page 1